Principal Financial Group Inc Intellia Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$20.02 - $27.22 $153,973 - $209,349	-7,691 Reduced 37.42%	12,860 $287,000
Q1 2024 Apr 29, 2024	SELL	$23.82 - $32.8 $30,799 - $42,410	-1,293 Reduced 5.92%	20,551 $565,000
Q4 2023 Feb 07, 2024	SELL	$23.16 - $32.34 $49,122 - $68,593	-2,121 Reduced 8.85%	21,844 $666,000
Q3 2023 Nov 02, 2023	BUY	$31.62 - $45.78 $108,772 - $157,483	3,440 Added 16.76%	23,965 $757,000
Q2 2023 Aug 07, 2023	BUY	$34.58 - $46.03 $24,932 - $33,187	721 Added 3.64%	20,525 $837,000
Q1 2023 May 09, 2023	SELL	$33.3 - $44.82 $1,032 - $1,389	-31 Reduced 0.16%	19,804 $738,000
Q4 2022 Feb 09, 2023	BUY	$33.21 - $62.69 $41,612 - $78,550	1,253 Added 6.74%	19,835 $692,000
Q3 2022 Nov 09, 2022	BUY	$53.92 - $71.7 $55,807 - $74,209	1,035 Added 5.9%	18,582 $1.04 Million
Q2 2022 Aug 10, 2022	SELL	$38.49 - $76.21 $312,654 - $619,053	-8,123 Reduced 31.64%	17,547 $908,000
Q1 2022 May 09, 2022	SELL	$58.27 - $118.99 $157,620 - $321,867	-2,705 Reduced 9.53%	25,670 $1.87 Million
Q4 2021 Feb 09, 2022	SELL	$100.76 - $138.36 $9.38 Million - $12.9 Million	-93,053 Reduced 76.63%	28,375 $3.36 Million
Q3 2021 Nov 09, 2021	BUY	$132.37 - $176.78 $903,160 - $1.21 Million	6,823 Added 5.95%	121,428 $16.3 Million
Q2 2021 Aug 10, 2021	BUY	$60.88 - $161.91 $5.46 Million - $14.5 Million	89,624 Added 358.77%	114,605 $18.6 Million
Q1 2021 May 10, 2021	BUY	$46.59 - $83.68 $7,314 - $13,137	157 Added 0.63%	24,981 $2.01 Million
Q4 2020 Feb 08, 2021	BUY	$18.83 - $63.53 $270,907 - $914,006	14,387 Added 137.85%	24,824 $1.35 Million
Q2 2020 Aug 05, 2020	BUY	$11.14 - $22.87 $116,268 - $238,694	10,437 New	10,437 $219,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account